Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pediatric Blood and Cancer is Scopus-indexed (Q1, CiteScore 3.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Liss Inc..
Checked against the index lists dated .
ISSN 1545-5009Verify ISSN ↗1545-5017Verify ISSN ↗
Publisher: Wiley-Liss Inc.
Cost to publish: About US$4,640 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pediatrics, Perinatology and Child Health | 88 / 351 | 75th | Q1 |
| Hematology | 62 / 151 | 59th | Q2 |
| Oncology | 222 / 428 | 48th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2004–present, best quartile Q1, CiteScore 3.9.
Pediatric Blood and Cancer is Q1 in Pediatrics, Perinatology and Child Health (rank 88 of 351), Q2 in Hematology (rank 62 of 151) and Q3 in Oncology (rank 222 of 428), by CiteScore 2025.
Pediatric Blood and Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.9, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.916, quartile Q1, with an H-index of 138.
The publisher lists an article processing charge of about US$4,640 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pediatric Blood and Cancer is published by Wiley-Liss Inc. Its print ISSN is 1545-5009 and its online ISSN is 1545-5017.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Pediatric Blood and Cancer has an h-index of 146 and a 2-year mean of 1.5 citations per paper (OpenAlex). Its Scopus CiteScore is 3.9, quartile Q1. On 2-year citations it ranks #108 of 344 Scopus journals in Pediatrics, Perinatology and Child Health.
Pediatric Blood and Cancer published 751 papers in 2025; its busiest recent year was 2020 with 752. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (37.9%), China (7%) and Türkiye (5.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (0.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.